A new study assessed whether cannabis can help those with Tourettes, Oregon and Maryland are making progress on psychedelic reform, and Idaho is getting a chance to legalize medical cannabis.
Let’s dive into this week’s cannanews.
Study Analyzes Cannabis’ Effects on Tourettes Patients
A new study published in the journal Cannabis and Cannabinoid Research looked at how medical cannabis could improve the lives of those with Tourettes syndrome.
The study enlisted the help of 70 patients with Tourettes. The patients were given daily doses of a cannabis product with 123 milligrams of THC and 50.5 milligrams of CBD. The participants’ well-being was assessed before the experiment began and then again six months later to gauge the cannabis treatment’s effects.
At its completion, the study found that patients experienced an overall improvement in their quality of life. Further, patients also reported vast reductions in their anxiety and obsessive-compulsive disorders.
All that being said, the study also uncovered a few symptoms that were not improved by the cannabis treatment. Specifically, the frequency of tics did not change among the participants.
While the study’s findings are promising, researchers say that more studies are necessary to evaluate the efficacy and safety of these cannabis treatments.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
- Get approved or your money back
- Appointments available on-demand
- Customer support available 24/7
What do you think of this Tourettes study’s findings? Let us know in the comments!
Oregon and Maryland Make Psychedelic Progress
Psychedelic history is being made on both coasts as Oregon and Maryland inch closer to legal use.
In November 2020, Oregon passed a law legalizing the regulation, production, and sale of psilocybin products for therapeutic purposes. Fast-forward to 2023, and the state has now granted the first of these psilocybin manufacturing licenses to Satori Farms PDX LLC. With over 220 license applications submitted to date, more approvals are expected in the coming months.
Meanwhile, in Massachusetts, advocates are pushing to decriminalize psilocybin statewide. Currently, psilocybin decriminalization only applies to certain municipalities in the state, like Somerville, Cambridge, and Northampton. Thanks to the efforts of the Bay Starters for Natural Medicine, a total of eight psychedelics-related bills are currently making their way through Massachusetts’ legislature.
Make sure to check in with Veriheal to get the latest updates on the progress of these two states’ psychedelic legalization efforts.
Idaho Bill Seeks to Legalize Medical Cannabis
Medical cannabis could soon become a reality in Idaho—however, there’s a catch. Last week Idaho House Health and Welfare Committee Chairman John Vander Woude filed a personal bill to legalize cannabis for medical use.
Unfortunately, the bill specifies that medical cannabis patients will only have access to a limited selection of cannabis products. Specifically, only cannabis products like pills, tablets, and chewables with a maximum THC content of 10 milligrams would be available.
Under the bill, those with the following ailments will qualify for a medical cannabis card:
- Alzheimer’s disease
- Amyotrophic lateral sclerosis
- Severe chronic pain
- Irritable bowel syndrome or ulcerative colitis
- Epilepsy or debilitating seizures
- Multiple sclerosis
- Any terminal illness
What do you think of Idaho’s somewhat limited medical cannabis plans? Let us know in the comments!